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Abstract
In this study, a five-generation Chinese family (family F013) with progressive autosomal dominant hearing loss was mapped
to a critical region spanning 28.54 Mb on chromosome 9q31.3-q34.3 by linkage analysis, which was a novel DFNA locus,
assigned as DFNA56. In this interval, there were 398 annotated genes. Then, whole exome sequencing was applied in three
patients and one normal individual from this family. Six single nucleotide variants and two indels were found co-segregated
with the phenotypes. Then using mass spectrum (Sequenom, Inc.) to rank the eight sites, we found only the TNC gene be
co-segregated with hearing loss in 53 subjects of F013. And this missense mutation (c.5317G.A, p.V1773M ) of TNC located
exactly in the critical linked interval. Further screening to the coding region of this gene in 587 subjects with nonsyndromic
hearing loss (NSHL) found a second missense mutation, c.5368A.T (p. T1796S), co-segregating with phenotype in the other
family. These two mutations located in the conserved region of TNC and were absent in the 387 normal hearing individuals
of matched geographical ancestry. Functional effects of the two mutations were predicted using SIFT and both mutations
were deleterious. All these results supported that TNC may be the causal gene for the hearing loss inherited in these
families. TNC encodes tenascin-C, a member of the extracellular matrix (ECM), is present in the basilar membrane (BM), and
the osseous spiral lamina of the cochlea. It plays an important role in cochlear development. The up-regulated expression of
TNC gene in tissue repair and neural regeneration was seen in human and zebrafish, and in sensory receptor recovery in the
vestibular organ after ototoxic injury in birds. Then the absence of normal tenascin-C was supposed to cause irreversible
injuries in cochlea and caused hearing loss.
Citation: Zhao Y, Zhao F, Zong L, Zhang P, Guan L, et al. (2013) Exome Sequencing and Linkage Analysis Identified Tenascin-C (TNC) as a Novel Causative Gene in
Nonsyndromic Hearing Loss. PLoS ONE 8(7): e69549. doi:10.1371/journal.pone.0069549
Editor: Andreas R. Janecke, Innsbruck Medical University, Austria
Received May 11, 2013; Accepted June 11, 2013; Published July 30, 2013
Copyright:  2013 Zhao et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by the grants of the National Natural Science Foundation of China, Major Project, No. 81120108009 and National Natural
Science Foundation of Youth Science Foundation No.81100719. The funders had no role in study design, data collection and analysis, decision to publish, or
preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: wqcr@263.net
. These authors contributed equally to this work.
Introduction
There are a total of 278 million people suffering from hearing
loss in the world, while in China the number amounts to 2.78
million. More than 60% of cases can be attributed to genetic
causes and inherited across generations. Approximately 70% of
hereditary hearing loss is nonsyndromic and caused by monogenic
mutations. About 22–25% of them is autosomal dominant
nonsyndromic sensorineural hearing loss (ADNSHL) [1]. To date,
more than 60 loci and 27 responsible genes for autosomal
dominant hearing loss had been identified (hereditary Hearing
Loss homepage, http://hereditaryhearingloss.org/). Most of these
genes were identified through the traditional positional cloning
and sequencing each gene in the critical interval one by one
according to the gene function and expression pattern. The scope
of this method however, is limited, especially in situations where
there are a large number of genes in the mapped region. However,
recent advances in exome sequencing (i.e., sequencing of all
protein-coding regions of the genome) approach has shown the
sensitivity and accuracy in the identification of the causal genes of
several rare monogenic diseases such as Miller syndrome [2],
especially in diseases inherited in recessive pattern. However,
exome sequencing is an unbiased method to all genes. It adds the
difficulties in identifying the heterozygous mutation responsible for
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autosomal dominant disease. Family-based linkage analysis could
map the responsible gene in a special region, which is a more
accurate compared to exome sequencing. Thus combinational
strategy using linkage analysis and exome sequencing provides a
powerful and affordable means to identify causative genes
especially in autosomal dominant mode.
Here we report a five-generation Chinese family (family F013)
with autosomal dominant hereditary hearing loss mapped on
chromosome 9q31.3-34.3 (28.54 Mb) in 2004, where there are
398 predicted and reported genes. Six years later after gene
mapped, we successfully identified a novel causative gene for this
type of hearing loss in family F013, TNC (Tenascin-C,
NC_000009.11, NM_002160.2, NP_002151.2), applying the
combined strategy of linkage analysis and whole-exome sequenc-
ing. The causal role of this gene was supported by several lines: (I)
the co-segregation of mutation with the phenotype; (II) its absence
in 387 unaffected individuals of matched geographical ancestry;
(III) the conservative nature of the mutation site; (IV) identification
of another missense mutation of TNC in a two-generation Chinese
hearing loss family; (V)TNC encoding protein, tenascin-C is a
member of extracellular matrix (ECM) glycoprotein, and there
have some reports about the pathological function of ECM
proteins in hereditary hearing loss, such as Usherin [3] and cochlin
[4]. (VI) Tenascin-C expresses under basilar membrane (BM) in
cochlea, and is important for auditory development and self-
recovery from injuries. BM proteins (laminin [5] and collagen 4
[6]) have been reported involved in hearing loss.
Materials and Methods
Ethics Statement
The study was approved by the Committee of Medical Ethics of
Chinese People’s Liberation Army (PLA) General Hospital. We
obtained a written informed consent from all the participants in
this study. Written informed consent was obtained from the next of
kin on the behalf of the minors/children participants involved in
this study.
Family Ascertainment and Clinical Diagnosis
A five-generation family (F013) with 70 members segregating
ADNSHL was investigated from the Department of Otolaryngol-
ogy, Head and Neck Surgery, the Chinese PLA (People’s
Liberation Army) General Hospital, China (Figure 1). All
participants underwent clinical and audiological evaluation,
including physical examination, pure-tone audiometry, tympano-
metry, acoustic reflex, ABRs and DPOAE. The audiological data
were evaluated based on the criteria established by European
Working Group on Genetics of Hearing loss. High resolution
computed tomography (HRCT) was also performed on some
subjects to verify whether the family members had other
complications other than hearing disorders. Environmental factors
were also excluded as causes of hearing loss.
Peripheral blood samples were obtained and genomic DNA was
extracted according to standard procedures, from a variety of
affected and unaffected individuals. The first set of analysis was the
five-generation Chinese hearing loss family, F013, a total of 22
subjects of which were included in the linkage study(II:2, III:1–5,
III:7, III:9–11, IV:1–3, IV:5, IV:9, IV:11, IV:13, IV:17, IV:29,
IV:31–32, V:1) and four individuals (IV:3, IV:5, IV:17, IV:31)
were included in exome sequencing study (Figure 1). A cohort of
587 subjects with SNHL were chosen as the other affected set for
further analysis. In these families the common gene associated to
hearing loss, such as GJB2, SLC26A4 and mitochondrial DNA
A1555G mutations were all excluded. And 387 unaffected
individuals of matched geographical ancestry were recruited for
this study.
Genotyping and Linkage Analysis
A genome-wide screening was performed with 394 microsatel-
lite markers distributed with an average spacing of 10 cM intervals
(ABI Prism Linkage Mapping Set 2 MD10, Applied Biosystems,
Foster City, CA, USA). Additional markers for fine mapping of the
linked chromosomal region were taken from the Marshfield
chromosome 9 map (http://research.marshfieldclinic.org/
genetics) and were also amplified using fluorescent-labeled primers
(Table S1, Shenggong DNA Technologies, Shanghai China).
Multiplex PCR was performed using standard procedures with
PE9700 thermocyclers (Applied Biosystems), producing a final
volume of 5 ml reaction mixture containing 30 ng of genome
DNA, 16PCR buffer, 0.2 mM of each dNTP, 3.0 mM MgCl2,
80 pmol of each forward and reverse primer, and 0.2 U of
AmpliTaq Gold polymerase. PCR products were loaded onto a
6% denaturing polyacrylamide gel (7 M urea) and visualized on an
ABI 3700 sequencer. Alleles were analyzed with ABI GeneMapper
(version 3.0).
Two-point linkage between the disease locus and the markers
was evaluated using the MILNK program of the LINKAGE
software package (version 5.1). The disease was assumed to be an
autosomal dominant disorder with a disease allele frequency of
0.0001 (an educated guess based on previous genetic epidemio-
logical data). The allelic penetrance was set at 90% considering the
genetic heterogeneity of hereditary hearing loss. For the micro-
satellite marker loci, equal allele frequencies were used. The
genome-wide scan genotypic data of the 11 affected individuals
were also analyzed using GeneHunter to obtain multipoint LOD
scores. Haplotype analysis was constructed with the Cyrillic
software version 2.1 (Cyrillic Software, Wallingford, UK).
Exome Capture
Qualified genomic DNA samples (6 ug) of the F013 family
members were sheared by sonication. Then the fragment of each
sheared genomic DNA sample was hybridized to the SureSelect
Biotiny lated RNA Library (BAITS) for enrichment.
Exome Sequencing, Reads Mapping and SNP Detection
The enriched libraries were loaded on the HiSeq 2000 platform
to be sequenced. Raw image files were processed by Illumina
Pipeline v1.6 for base-calling with default parameters and the
sequences of each individual were generated as 90 bp paired-end
reads. And then the sequenced raw data was aligned to the the
NCBI human reference genome (Build 36.3) using SOAPaligner
[7]. After that, the duplicate reads were filtered out and the clean
reads located in the target region were collected. Then the
consensus genotype and quality were estimated by SOAPsnp
(version1.03) using the clean reads. The low quality variations
were filtered out by the following criteria: (i) quality score,20
(Q20); (ii) average copy number at the allele site.=2; (iii) distance
of two adjacent SNPs,5 bp; and (iv) sequencing depth,4 or
.500.
Detection of Insertions and Deletions
Insertions and deletions (indels) in the exome regions were
identified through the sequencing reads. We aligned the reads to
the reference genome by Burrows-Wheeler Aligner (BWA0.5.8 )
[8], and passed the alignment result to the Genome Analysis
Toolkit (GATK1.0.4705) to identify the breakpoints. Finally, we
annotated the genotypes of insertions and deletions [9].
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Sequencing Analysis of Candidate Gene
As the candidate gene of F013, TNC gene was selected for
mutation screening in members available of F013, 587 subjects
with SNHL and the 387 unaffected individuals. TNC gene
contains 28 exons. Thirty-two primer pairs were designed using
online Primer 3.0 software and synthesized by Invitrogen by life
technology (Table S2, Beijing, China) to amplify each exon and
exon-intron boundaries. PCR was performed with PE9700
thermocyclers (Applied Biosystems). The reaction mixture con-
tained 100 ng DNA, 1.5 units of DNA Taq polymerase (TaKaRa,
Dalian, China), 200 mM dNTPs, 3 pmol of each forward and
reverse primer, 2.5 mL of 106 buffer (with 2.5 mM MgCl2) and
the final reaction volume was filled to 25 mL with ddH2O. After
PCR amplification, 5 ml PCR products were separated on 1%
agarose gel and purified using Millipore filter plates. Sequence
analysis was performed on an automated sequencer (ABI 3730,
Applied Biosystems) for both affected and normal individuals of
the family. Nucleotide alterations including mutations and
polymorphisms were identified by sequence alignment with the
NCBI Reference Sequence (Build 36.3) using the DNAStar software
5.0 version (DNASTAR, Madison, WI, USA).
Results
Family Recruitment and Clinical Features
A total of 53 family members, composed of 11 clinical affected and 42
unaffected individuals (37 presumptive unaffected family members
and 5 clinically unknown subjects younger than the average onset age), were
recruited in this study (Figure 1). Affected members in F013 showed a
postlingual, symmetrical, and bilateral nonsyndromic sensorineu-
ral hearing loss (Figure 2A). The hearing loss was initially
presented as mild in low frequencies with subsequent gradual
progression to severe level involving all frequencies with time
(Figure 2A). Age of onset varied from 8 to 30 years old. No
vestibular symptoms or signs were reported. High resolution CT
scan showed normal middle and inner ears structure, including
normal vestibular aqueduct and internal auditory canal. Compre-
hensive examination of the family medical history did not identify
any other clinical syndromic feature.
Linkage Analysis
Twenty-two of the 53 subjects in F013 were enrolled in the
linkage study (Figure 2B). The genome-wide linkage analysis of
F013 located the deafness gene on the long arm of chromosome 9.
Significant linkage was found with markers D9S164 and D9S1826
(positive two-point LOD scores of 3.44 and 3.31 at = 0,
respectively, Table 1) within the chromosomal region 9q31.3-
34.3 (Figure 2C). Fine mapping of the region using additional
microsatellite markers (Table S1) confirmed the linkage. The
maximum two-point LOD score of 4.57 ( = 0) was obtained with
marker D9S177 in chromosomal region 9q33 (Table 1). This
candidate region showed partial overlap with the critical intervals
identified in DFNB31 (9q32-34) and DFNB79 (9q34.3) loci
(Figure. 2C), both of which inherited in autosomal recessive
pattern. Thus, the critical interval mapped on chromosome
9q31.3-34.3 in this study is a novel DFNA locus, assigned as
DFNA56 by Human Genome Organization (HUGO) nomencla-
ture committee (http://www.gene.ucl.ac.uk/nomenclature/).
Exome Sequencing Identified a Candidate Gene
Three affected individuals (IV:5, IV:17, IV:31) and one normal
hearing (IV:3) member of F013 were included in whole exome
sequencing study. We obtained an average of 4.7 billion bases of
sequence per individual as paired-end, 90 bp reads, and about
65% of the total bases mapped to the exomes with a mean
coverage of 50-fold (Table S3, Figure S1 and Figure S2). At this
depth of coverage, 98% of the targeted region was sufficiently
covered to pass our thresholds for variant calling. By exome
sequencing, we detected 240 coding insertions or deletions (Indels).
To identify SNPs, we used SOAPsnp software and bioinformatics
pipeline. A total of 7,580 non-synonymous/splice acceptor and
donor site/insertions or deletions (NS/SS/Indel) variants were
detected in at least one of the affected individuals (Table S4 and
Table S5). After comparison with SNP databases, including
dbSNP132, the 1000 Genome Project (10/2010 release), HapMap
data (HapMap 8/2010 release), and YH (Asian), we identified 6
rare SNPs and 2 indels in transcribed sequences that co-segregated
with the phenotype in these 4 subjects (Table 2). Among them, a
missense mutation c.5317G.A (p.V1773M) in exon 19 of the
TNC gene, is just located in the critical linked region of 9q31.3-
Figure 1. Pedigree of F013. Filled symbols for males (squares) and females (circles) represent affected individuals, and empty, unaffected ones. An
arrow denotes the proband. Symbols with dot indicate the individual younger than the average age of onset, who are mutation carrier but does not
present hearing loss (a mutation carrier).
doi:10.1371/journal.pone.0069549.g001
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34.3 (Table 3). We screened the whole exon19, where the variant
located in TNC, in all 53 members of F013 using Sanger
sequencing. Results found that all 11 patients were heterozygous
for this mutation and none of the clinically unaffected family
members carried this variant, which is co-segregated with the
hearing loss phenotype (Figure 2E). Furthermore, six candidate
SNPs and 2 indels in transcribed sequences found in exome
sequencing were also genotyped using the Sequenom MassAR-
RAY platform (Sequenom, Inc.) in all family members obtained.
Except the mutation c.5317G.A in TNC, none of the other seven
variants were co-segregated with the hearing loss.
Multiple sequence alignment in other organisms (including
human, macaque, chimpanzee, elephant, pig, platypus and
zebrafish) revealed the mutation was present in a highly conserved
position (Figure S3). We assessed the functional impact of
p.V1773M on the protein using SIFT (version 4.0.3) and Align-
GVGD software, and this mutation was predicted to be
functionally deleterious. We used PolyPhen-2 software (DeLano
Scientific LLC) to study 3D structure of the protein, and found
that mutation (p.V1773M) changes the shape of the protein in this
region, which may alter its ability to bind to other molecules. This
mutation was located in an exon that was present in all RNA
isoforms. There is no total length of tenascin precursor in Protein
Data Bank (PDB), and we took the FN-III domain structure in rat
that is similar to TNC sequence as the template (PDB: 1TDQ,
PubMed: 15296743, Sup. file 1) After comparison, the mutation
located in the rim of conjunction of two conservative domains in
FN-III domain, which was the most functional part of tenascin-C
for ligand binding (Figure S4).
Mutation Spectrum of the TNC Gene
To confirm the results, we sequenced the whole 28 exons of
TNC gene in 587 subjects with SNHL that have unknown genes.
We found a second mutation in a three-generation Chinese
Figure 2. Gene mapping of F013 with autosomal dominant progressive hearing loss and audiological evaluation of affected family
members. (A) Audiograms of the proband (IV:11). Symbols ‘‘o’’ and ‘‘x’’ denote air conduction pure-tone thresholds at different frequencies in the
right and left ear. dB, decibels; Hz, Hertz. The proband is most affected in low frequencies with ascending audiological curve. The age at the time of
audiological examination with dotted line was 18 years old. Audiological examination with solid line was performed ten years later. The hearing loss
progresses gradually with age. (B) Haplotype analysis of F013. Haplotypes for the markers on chromosome 9q31.3-34.3 are shown by bars, with the
haplotype associated with hearing loss in red which defines the critical DFNA56 region between flanking markers D9S1677 and D9S1838. (C)
Schematic physical and genetic maps of DFNA56 locus on the 9q31.3-34.3 chromosomal region. The previously reported loci, DFNB31 and DFNB79
which are overlapped with DFNA56 are also shown. The TNC gene is indicated. Mb, million base pairs. (D) Structure of TNC gene. TNC gene has 28
exons. Mutations of c.5317G.A (p.V1773M) and c.5368A.T (p.T1796S) identified in TNC gene are both located in exon 19, which corresponds to the
13th FN-III domain in the translated protein. (E) & (F) Sequencing chromatograms of TNC showing the two heterozygous transitions, c.5317G.A and
c.5368A.T in affected individuals (upper panel) compared with those of normal controls (lower panel). The two mutated nucleotides are marked by
red arrows. The predicted amino acid changes and surrounding ones are indicated above the sequences. (G) Tenascin-C is composed of a TA domain,
a linear array of epidermal growth factor-like (EGFL) repeats, a series of fibronectin type III (FN-III) domains, and a globular domain at the terminal.
doi:10.1371/journal.pone.0069549.g002
Table 1. Two-point LOD scores between 9q microsatellite markers for F013.
Markers Genetic Physical LOD SCORE AT h = Zmax hmax
Distance(cM) Distance(bp) 0 0.1 0.2 0.3 0.4 0.5
D9S1690 106.63 103143785 213.39 21.03 20.05 0.27 0.25 0 0.29 0.344
D9S1677 117.37 110981204 22.1 2.86 2.38 1.68 0.83 0 2.93 0.061
D9S1856 120.04 113986910 3.11 2.63 2.1 1.49 0.81 0 3.11 0
D9S289 120.77 115455388 4.31 3.6 2.81 1.92 0.94 0 4.31 0
D9S1824 122.23 115931926 0.97 0.81 0.64 0.45 0.24 0 0.97 0
D9S1776 123.33 116999255 2.55 2.07 1.54 0.94 0.34 0 2.55 0
D9S177 123.87 117499409 4.57 3.82 2.99 2.05 1.01 0 4.57 0
D9S154 125.63 118380667 2.84 2.36 1.83 1.22 0.56 0 2.84 0
D9S1872 129.74 120829322 4.27 3.57 2.79 1.91 0.93 0 4.27 0
D9S1116 130.52 122032251 2.58 2.14 1.65 1.1 0.49 0 2.58 0
D9S1682 132.09 124033006 2.38 2.08 1.69 1.22 0.67 0 2.38 0
D9S1881 135.85 126019300 3.44 2.87 2.23 1.51 0.72 0 3.44 0
D9S1840 136.47 126327340 2.58 2.1 1.55 0.95 0.33 0 2.58 0
D9S290 140.86 130567273 1.11 0.94 0.75 0.53 0.29 0 1.11 0
D9S1795 142.51 131346313 1.63 1.33 0.99 0.62 0.23 0 1.63 0
D9S1861 144.13 132310567 2.88 2.39 1.85 1.23 0.56 0 2.88 0
D9S1830 145.21 134655582 4.31 3.6 2.81 1.92 0.94 0 4.31 0
D9S164 147.91 135195754 3.44 2.87 2.23 1.51 0.71 0 3.44 0
D9S1826 159.61 137551425 3.31 2.92 2.35 1.63 0.8 0 3.31 0
D9S158 161.71 138202283 0.02 0.02 0.01 0.01 0 0 0.02 0
D9S1838 163.84 139519106 23.19 1.49 1.36 0.99 0.47 0 1.5 0.115
doi:10.1371/journal.pone.0069549.t001
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hearing loss family (Family 6957 with 5 patients; Figure S5) in
exon19 of TNC, which was a missense variant c.5368A.T
transition (p. T1796S) (Figure 2F) and completely co-segregated
with the hearing loss phenotype in all 5 patients. Hearing loss in
this family was late onset and the high frequency was initially
decreased (Figure S6). It’s interesting that three patients (II:1, II:8,
II:12) also carried the mitochondrial mutation of 1555A.G.
Additionally, we found 15 non-synonymous variants in heterozy-
gous pattern (Table S6 and Table S7). These variants were rare
and carried by one or two individuals only, nine of them were
novel variants which have never be reported in public database
(Table S7). SIFT predicted that four variants from the nine was
damaging. Details of six patients with the four TNC variants were
described in the supplementary materials (Table S8). To assess the
frequency of the mutation with p.V1773M and p.T1796S in
population, we sequenced 387 geographically matched controls
and neither mutation was found in the samples at present.
Discussion
The F013 has been mapped to 9q33 by linkage analysis six years
ago by our team, but the causative gene was not identified because
of too many candidate genes involved in this mapped locus. This
caveat is common and unconquerable in the study of hereditary
hearing loss because of the intrinsic defect of traditional method.
Now, about 80 loci in 155 for nonsyndromic sensorineural hearing
loss (NSSHL) including 30 dominant NSSHL loci remain to be
identified. Strong power of exome sequencing technology in
identifying causative gene has been exemplified for monogenic
disease [2], and gradually for common diseases [10]. Previous
study showed that this new technique is especially fit for diseases in
recessive inheritance mode, because in domiant inherited mode
the heterozygosity will be causative and be clinically effective and
too many functional SNPs would be identified. However, exome
sequencing is unbiased to detect all functional variants in coding
region. After filteration by public data and familial controls,
damaging mutations emerged. Then, by the help of exact location
of linkage analysis, redundant mutations will be excluded and we
could detect the causal mutation underlie F013. Using this
strategy, combination the mapped interval by classical linkage
analysis with results of exome sequencing, only one causative
mutation were confirmed. The combination of linkage analysis
and exome sequencing provided strong evidence that TNC may be
responsible for hearing loss in this family. The causative evidence
was elaborated in introduction and concrete procedures could be
seen in methods and results.
TNC gene encodes an extracellular matrix protein and has a
highly conserved sequence in different species, for example, the
sequence originated from the mouse has about 74% human
similarity and the zebrafish is about 72%. The gene product
tenascin-C has a structure like hexabrachion, composing of a TA
domain, a linear array of epidermal growth factor-like (EGFL)
repeats, a series of fibronectin type III (FN-III) domains, and a
globular domain at the terminal (Figure 2G) [11]. The most
important functional part of the protein is the FN-III domains. We
used Protein Data Bank (PDB) archive to predict the protein
structure change of Tenascin-C with mutations. We found that
both mutations located in the rim the conjunction of two
conservative domains in FN-III domain, which was the most
functional part of tenascin-C for ligand binding. Mutation
p.V1773M changes the shape of the protein in this region and
tightens the distance of two adjacent FN-III domains, which may
alter its ability to bind to other molecules (Figure S4). Although
p.V1773M was recorded in dbSNP as a known variant, it is a rare
SNP with very low frequency as shown in the ssSNP report
(http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ss.
Table 2. Identification of the causal gene by whole-exome sequencing and linkage analysis.
Filter process
IV:5
(Whole/locus)
IV:17
(Whole/locus)
IV:31
(Whole/locus)
IV:5+IV:17
(Whole/locus)
IV:5+IV:17+IV:31
(Whole/locus)
NS/SS/Indel 7515/160 7483/170 7401/165 5071/130 4081/120
Not in dbSNP 132_1000 Genomes_HapMap_YH 540/10 524/9 486/9 130/4 51/3
Not in dbSNP 132_1kgenomes_Hapmap_YH_control 303/3 398/6 387/7 48/2 8/1
The number of functional variants (non-synonymous/splice acceptor and donor site/insertions or deletions) is listed under various filters. Variants were filtered by
presence in dbSNP, 1000 Genomes, HapMap 8 or YH (Not in dbSNP 132_1000 Genomes_HapMap_YH) and control exomes (Not in
dbSNP_1kgenomes_Hapmap_YH_control). (Whole/locus): indicate NS/SS/Indel variants be observed in whole exome or in locus region by linkage analysis.
doi:10.1371/journal.pone.0069549.t002
Table 3. Candidate variants shared by three affected individuals of F013.
Chromosome Position Reference Change Gene Codons Substitution
Chr6 151714872 A T AKAP12 AAA-AtA K1218I
Chr6 152671466 A – SYNE1 Splice site deletion
Chr7 151601810 G T MLL3 CCT-tCT P309S
Chr9 116843116 C A TNC GTG-aTG V1773M
Chr10 51282920 T G TIMM23 AGA-gGA R112G
Chr16 28511211 C T SULT1A2 GAG-tAG E217X
Chr17 77866494 A C CD7 TAC-cAC Y239H
Chr19 45786926 GAGGACAGTCCTGTCCAACAGGGAGG SHKBP1 Splice site deletion
doi:10.1371/journal.pone.0069549.t003
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cgi?ss = ss342281564). The actual ratio was below 0.0005, and the
number of subjects found by NCBI was 2 (2/4552=0.0004393).
The similar artifact was also seen in the study from Walsh. They
found a pathogenic mutation in dbSNP, but not in 768 controls.
The reason was thought to be the use of uncurated variant
database [12].
Tenascin-C, a glycoprotein, a member of the extracellular
matrix (ECM), was expressed in the basilar membrane and the
osseous spiral lamina in the human cochlear, which is one of the
primary components in mammalian basilar membrane as collagen
4, laminin, nidogen, and dystroglycan. Because the basilar
membrane in the inner ear regulates fluid and ion transport
between the endolymph and perilymph [13], mutated components
of the basilar membrane could lead to disturbance of ionic
homeostasis and result in hearing loss, as shown by laminin [5] in
nonsyndromic deafness and an altered expression of collagen IV
chains in Alport’s syndrome [6]. And other proteins in ECM have
also been shown to be involved in hereditary hearing loss, for
example, mutated Usherin caused Usher syndrome IIA and
mutated collagen XI caused nonsyndromic deafness [14].
Tenascin-C managed the recovery of sensory receptors in
vestibular organ in birds after ototoxic injury [15]. The ability of
spontaneous recovery after spinal lesion in adult zebrafish could
also be explained by the promotion of tenascin-C [16]. And some
studies in human have also conducted the conclusion that
tenascin-C play an important role in the tissue repair and
restoration in skeletal system [17], and in tissues remodeling after
myocardial injury [18]. Considering the remarkable sequence
conservation in different species, it is speculated the similar
impulse in repairment in human cochlea. Under mutated
conditions, the altered protein couldn’t bind to other extracellular
matrix proteins, ligands and cell receptors, and the repair
mechanism after reversible injuries would not work. The
vulnerabilities of cochlea caused the accumulation of detriment
and the hearing loss progressed.
In summary, using a combination of linkage analysis and
exome-sequencing enabled us to use a single pedigree to identify a
novel hearing loss gene. These findings suggest the usefulness and
decreased cost that whole exome-sequencing can provide for gene
identification in hereditary NSHL and other dominant Mendelian
diseases. Additionally the identification of TNC here adds new
evidence for the importance of BM proteins in hereditary hearing
loss.
Supporting Information
Figure S1 The distribution of per-base sequencing
depth in target regions for each sample. Y-axis indicated
the percentage of total target region under a given sequencing
depth.
(TIF)
Figure S2 Cumulative depth distribution in target
regions for each sample. X-axis denotes sequencing depth,
and y-axis indicated the fraction of bases that achieves at or above
a given sequencing depth. From the figure above, we can see about
75.50% of target region bases obtains at least 206 fold coverage,
that is to say, about 75.50% of target region was covered by more
than 20 reads. And about 89.10% of target region achieved at least
106.
(TIF)
Figure S3 Multiple amino acid sequence alignment of
TNC using ClustalW software. The conservation analysis
shows that p.V1773M (red arrow) and p.T1796S (red arrow)
heterozygous missense mutation in TNC is at a highly conserved
position by comparison to the corresponding sequence of human,
macaque, chimpanzee, elephant, pig, platypus and zebrafish.
(TIF)
Figure S4 Comparison of normal and mutated protein
configuration of tenascin precursor. The image in cyan is
the configuration prediction of normal protein. Sites of p.1773V
and p.1796T are in purple. The image in green is the
configuration prediction of mutated protein. Mutated sites of
p.1773M and p.1796S are in yellow. And local zoom of normal
and changed (p.V1773M) protein configuration emphasized by
yellow circles.
(TIF)
Figure S5 Pedigree of 6957. Filled symbols for males (squares)
and females (circles) represent affected individuals, and empty,
unaffected ones; An arrow denotes the proband.
(TIF)
Figure S6 Audiograms of the patients in family 6957.
Symbols ‘‘o’’ and ‘‘x’’ denote air conduction pure-tone thresholds
at different frequencies in the right and left ear, symbol
‘‘%’’denote marked air conduction pure-tone threshold with
white noise. dB, decibels; Hz, Hertz. The age at the time of
audiological examination was recorded.
(TIF)
Table S1 Details of the 14 Markers used for fine
mapping.
(DOCX)
Table S2 Primer sequences for each exon in TNC.
(DOCX)
Table S3 Summary of Effective Data for exome se-
quencing. *The region near target refers to flanking region
within 200 bp of target regions. **Total effective reads is the same
meaning as the unique mapped reads which was stated in the
pipeline above. Here the effective reads consist of two parts: i) the
reads have only one best hit in the alignment. These reads comes
from the unique region of genome ii) the reads have multiple best
hits on the genome (the number of hits between 1 and 20), and
they were randomly aligned onto the target regions. These reads
mainly come from low complex genomic region, such as repetitive
sequences, and account for about 4% of total effective reads.
***Target regions used here refer to genomic regions that the
Exome array actually covered. The aggregate length of target is
about 37.8 Mb.
(DOCX)
Table S4 Summary of SNPs in Exome Sequencing for
each Sample. *Consensus genotype with quality score of at least
20. **Intronic SNPs within 4 bp of exon/intron boundary. ***59
UTR refers to 200 bp upstream of initiation codon, 39UTR is
defined as 200 bp downstream of termination codon.
(DOCX)
Table S5 Summary of Indels in Exome Sequencing for
each Sample.
(DOCX)
Table S6 Nonsynonymous Variants of TNC in NSHL
subjects.
(DOCX)
Table S7 Nine Novel Nonsynonymous Variants of TNC
detected in NSHL subjects.
(DOCX)
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Table S8 Details of patients carried the deleterious
novel variants.
(DOCX)
Author Contributions
Conceived and designed the experiments: QW YZ. Performed the
experiments: YZ. Analyzed the data: PZ LG JZ Jing Wang LY XJ.
Contributed reagents/materials/analysis tools: DW WC LL QL BH.
Wrote the paper: YZ FZ LZ. Critical reading anddiscussion of manuscript:
WY XH XW NL YL CP Jun Wang HY Jian Wang QW.
References
1. Petersen MB (2002) Non-syndromic autosomal-dominant deafness. Clin Genet
62: 1–13.
2. Ng SB, Buckingham KJ, Lee C, Bigham AW, Tabor HK, et al. (2010) Exome
sequencing identifies the cause of a mendelian disorder. Nat Genet 42: 30–35.
3. Adato A, Lefevre G, Delprat B, Michel V, Michalski N, et al. (2005) Usherin, the
defective protein in Usher syndrome type IIA, is likely to be a component of
interstereocilia ankle links in the inner ear sensory cells. Hum Mol Genet 14:
3921–3932.
4. Robertson NG, Resendes BL, Lin JS, Lee C, Aster JC, et al. (2001) Inner ear
localization of mRNA and protein products of COCH, mutated in the
sensorineural deafness and vestibular disorder, DFNA9. Hum Mol Genet 10:
2493–2500.
5. Pillers DA, Kempton JB, Duncan NM, Pang J, Dwinnell SJ, et al. (2002)
Hearing loss in the laminin-deficient dy mouse model of congenital muscular
dystrophy. Mol Genet Metab 76: 217–224.
6. Barker DF, Hostikka SL, Zhou J, Chow LT, Oliphant AR, et al. (1990)
Identification of mutations in the COL4A5 collagen gene in Alport syndrome.
Science 248: 1224–1227.
7. Li R, LI Y, Kristiansen K, Wang J (2008) SOAP: short oligonucleotide
alignment program. Bioinformatics 24: 713–714.
8. Li H, Durbin R (2010) Fast and accurate long-read alignment with Burrows-
Wheeler transform. Bioinformatics 26: 589–595.
9. McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, et al. (2010) The
Genome Analysis Toolkit: a MapReduce framework for analyzing next-
generation DNA sequencing data. Genome Res 20: 1297–1303.
10. Stransky N, Egloff AM, Tward AD, Kostic AD, Cibulskis K, et al. (2011) The
mutational landscape of head and neck squamous cell carcinoma. Science 333:
1157–1160.
11. Jones FS, Jones PL (2000) The tenascin family of ECM glycoproteins: structure,
function, and regulation during embryonic development and tissue remodeling.
Dev Dyn 218: 235–259.
12. Walsh T, Shahin H, Elkan-Miller T, Lee MK, Thornton AM, et al. (2010)
Whole exome sequencing and homozygosity mapping identify mutation in the
cell polarity protein GPSM2 as the cause of nonsyndromic hearing loss
DFNB82. Am J Hum Genet 87: 90–94.
13. Anniko M, Wroblewski R (1986) Ionic environment of cochlear hair cells. Hear
Res 22: 279–293.
14. McGuirt WT, Prasad SD, Griffith AJ, Kunst HP, Green GE, et al. (1999)
Mutations in COL11A2 cause non-syndromic hearing loss (DFNA13). Nat
Genet 23: 413–419.
15. Warchol ME, Speck JD (2007) Expression of GATA3 and tenascin in the avian
vestibular maculae: normative patterns and changes during sensory regenera-
tion. J Comp Neurol 500: 646–657.
16. Yu YM, Cristofanilli M, Valiveti A, Ma L, Yoo M, et al. (2011) The extracellular
matrix glycoprotein tenascin-C promotes locomotor recovery after spinal cord
injury in adult zebrafish. Neuroscience 183: 238–250.
17. Nakoshi Y, Hasegawa M, Sudo A, Yoshida T, Uchida A (2008) Regulation of
tenascin-C expression by tumor necrosis factor-alpha in cultured human
osteoarthritis chondrocytes. J Rheumatol 35: 147–152.
18. Imanaka-Yoshida K, Hiroe M, Yoshida T (2004) Interaction between cell and
extracellular matrix in heart disease: multiple roles of tenascin-C in tissue
remodeling. Histol Histopathol 19: 517–525.
A Novel Nonsyndromic Hearing Loss Gene of TNC
PLOS ONE | www.plosone.org 8 July 2013 | Volume 8 | Issue 7 | e69549
